Author: Business Wire

Aerpio Therapeutics to Present TIME-2 Phase 2a Study of AKB-9778 in Diabetic Macular Edema Data at 2015 American Academy of Ophthalmology Annual Meeting Retina Subspecialty Day

CINCINNATI–(BUSINESS WIRE)–Aerpio Therapeutics, Inc., a biopharmaceutical company focused on advancing first-in-class treatments for the eye, today announced that data from the TIME-2 Phase 2a Study of AKB-9778 in the treatment of patients with diabetic macular edema (DME) will be presented at the upcoming American Academy of Ophthalmology (AAO) Annual Meeting’s Retina Subspecialty Day. In July, the company announced data showing that a combination of AKB-9778 and Lucentis® provided significa

Robins Kaplan LLP Named Co-Lead Counsel in Disposable Contact Lens Antitrust Litigation

NEW YORK–(BUSINESS WIRE)–National law firm Robins Kaplan LLP announced today that it has been named co-lead counsel in antitrust litigation against the four dominant manufacturers and the largest nationwide distributor of contact lenses. As co-lead counsel, Robins Kaplan represents a proposed class of individual consumers that purchased contact lenses from retailers and eye care professionals that could number in the millions. Robins Kaplan filed one of the first class action complaints on be

RightEye Neuro Vision Concussion Test Unveiled at American Academy of Optometry Show

NEW ORLEANS & WASHINGTON–(BUSINESS WIRE)–RightEye LLC, a health technology company using eye tracking to revolutionize vision performance and patient care, today announced at the 2015 American Academy of Optometry show in New Orleans the launch of RightEye Neuro Vision — a new 15-second concussion test that helps health care providers more clearly understand the severity of a patient’s head trauma and better assess their recovery over time. “It’s common for concussion patients to be in denial

Walmart Outlines New Ways It Is Helping Customers Live Healthy Lives

BENTONVILLE, Ark.–(BUSINESS WIRE)–Building on its commitment to making healthcare and healthier food more affordable and accessible, Walmart today outlined additional ways the company is helping its customers live healthier lives. The retailer will focus on preventive care and supporting overall well-being across its entire assortment – in stores and online – through in-store events, online education and an expanded assortment of products and services solutions. Customers will see Walmart’s c

Aerpio Appoints Steve Pakola, M.D. as Chief Medical Officer

CINCINNATI–(BUSINESS WIRE)–Aerpio Therapeutics, Inc., a biopharmaceutical company focused on advancing first-in-class treatments for the eye, today announced that Steve Pakola, M.D. has been appointed as the company’s first Chief Medical Officer. Dr. Pakola will lead the advancement of Aerpio’s development pipeline, including lead therapeutic candidate, AKB-9778. Dr. Pakola will report to Aerpio’s President and CEO Joseph Gardner, and his appointment is effective immediately. “Steve brings 20

Photometrics® Launches Intelligent Scientific CMOS Camera with Signal Restoration Super Powers

TUCSON, Ariz.–(BUSINESS WIRE)–Photometrics, a manufacturer of high performance scientific cameras for life science applications, today announces the release of its new sCMOS camera, the Photometrics Prime. Prime is the first 4.2 Megapixel scientific CMOS camera available for life science research that actively defeats the negative impact of Poisson noise in low light images. The camera packs a formidable FPGA-based Embedded Signal Processing engine, ESP™, that enables powerful signal restorat

Cegedim Announces the Signature of an Agreement to Acquire Nightingale’s US Business

BOULOGNE-BILLANCOURT, France–(BUSINESS WIRE)–Regulatory News: Cegedim, an innovative technology and services company, today announced the signature of an agreement for the acquisition of the US based Practice Management business of Nightingale Informatix Corporation by its US subsidiary Pulse System, Inc. The acquisition includes the assets of Nightingale’s Medrium, Ridgemark, Secure Connect and Northern Health Products. Jeff Burton, the Pulse Systems President and CEO stated that “We are exc

Presbia Introduces Time-Saving Disposable Microlens Inserter

DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ: LENS), an ophthalmic device company introduced its new, innovative disposable inserter for the Presbia Flexivue Microlens™ at the Australasian Society of Cataract and Refractive Surgeons (AUSCRS) conference held from October 7th through the 10th in Noosa, Queensland, Australia. The Presbia Flexivue Microlens is a proprietary optical lens implant for treating presbyopia, the age-related loss of near-vision. With its simplified action, the new inserte

Samenvatting: URSAPHARM GmbH en Novaliq GmbH sluiten Europese samenwerkingsovereenkomst

SAARBRÜCKEN, Duitsland & HEIDELBERG, Duitsland–(BUSINESS WIRE)–URSAPHARM, een van de toonaangevende Europese bedrijven op het gebied van oogheelkunde, en Novaliq, een farmaceutisch bedrijf dat gespecialiseerd is in de klinische fase dat een medicijnbezorgingstechnologieplatform heeft dat zich richt op de oogheelkunde, maken vandaag gezamenlijk hun samenwerkingsovereenkomst bekend, evenals de eerste lancering van EvoTears™. Als onderdeel van de overeenkomst verkrijgt URSAPHARM de exclusieve li

Resumen: URSAPHARM GmbH y Novaliq GmbH anuncian un acuerdo de colaboración en Europa

SAARBRÜCKEN y HEIDELBERG–(BUSINESS WIRE)–URSAPHARM, una de las empresas líderes en el campo de la oftalmología en Europa, y Novaliq, empresa farmacéutica especializada en estudios clínicos con una plataforma tecnológica para la distribución de fármacos centrada en la oftalmología, han anunciado hoy un acuerdo de colaboración así como el lanzamiento europeo de EvoTears™. El comunicado en el idioma original, es la versión oficial y autorizada del mismo. La traducción es solamente un medio de ay

URSAPHARM GmbH und Novaliq GmbH melden europäische Partnerschaftsvereinbarung

SAARBRÜCKEN und HEIDELBERG–(BUSINESS WIRE)–URSAPHARM, eines der führenden europäischen Unternehmen auf dem Gebiet der Augenheilkunde, und Novaliq, ein Unternehmen für pharmazeutische Spezialprodukte in der klinischen Entwicklung mit einer innovativen Drug-Delivery-Plattform mit Schwerpunkt in der Augenheilkunde, meldeten heute gemeinsam die Unterzeichnung der Partnerschaftsvereinbarung sowie den ersten Marktauftritt von EvoTears™ in Europa. Im Rahmen der Vereinbarung erhält URSAPHARM die exkl

Riassunto: URSAPHARM GmbH e Novaliq GmbH annunciano un accordo di collaborazione in Europa

SAARBRÜCKEN e HEIDELBERG, Germania–(BUSINESS WIRE)–URSAPHARM, una delle società europee leader nel settore dell’oftalmologia, e Novaliq, casa farmaceutica specializzata nella ricerca clinica con una piattaforma tecnologica innovativa per il rilascio dei farmaci oftalmici, hanno oggi annunciato la sigla di un contratto di collaborazione e il lancio di EvoTears™ sul mercato europeo. Come parte dell’accordo, URSAPHARM ottiene la licenza esclusiva per la commercializzazione di EvoTears, il primo